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A 19-year-old female was admitted to our hospital because of a sudden onset fever and cough, and she
was diagnosed to have acute eosinophilic pneumonia (AEP). The cause was thought to be cigarette
smoking, because she had started smoking just before the development of AEP and her condition
improved after cigarette smoking cessation, without corticosteroid treatment. The cytokines which are
thought to be involved in eosinophilic accumulation in the lungs were analyzed using bronchoalveolar
lavage ﬂuid (BALF) and serum. Of the analyzed cytokines, only regulated on activation, normal T cell
expressed and secreted (RANTES) increased in the serum after the improvement. RANTES is a unique
chemokine which attracts not only eosinophils, but also T cells. Interestingly, in this case, the eosinophil
count in the blood increased in parallel with the lymphocyte count after the improvement. These
ﬁndings are interesting because it may help to understand the pathogenesis of AEP and the role of
RANTES.
 2011 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Acute eosinophilic pneumonia (AEP) is a disease ﬁrst
described by Allen et al. in 1989, which is characterized by
eosinophilic inﬁltration in the lungs, respiratory distress, a rapid
therapeutic response to corticosteroids and the absence of
relapse.1 AEP induced by cigarette smoking was reported
recently,2e6 and it has been reported that there have been many
cases of cigarette smoking-induced AEP which showed sponta-
neous improvement without corticosteroids, following cigarette
smoking cessation.7
The pathogenic mechanism of AEP is not well understood.
However, some cytokines, such as interleukun-5 (IL-5) and eotaxin,
are thought to be associated with the eosinophilic inﬁltration in the
lung, and have been evaluated in some reports.8,9 We herein,
present the clinical course and the changes in the level of cytokine
expression with the time course in patient with cigarette smoking-
induced AEP which showed a spontaneous improvement after the
cessation of cigarette smoking.ima).
-NC-ND license.2. Case report
A 19-year old female was admitted to our hospital because of
a sudden onset fever and cough. She had developed the cough,
fever and progression of dyspnea two days before admission.
Antibiotic treatment prior to hospitalization was not effective for
the clinical symptoms. She had started to smoke 20 cigarettes per
day twoweeks before the admission. She had a history of pollinosis,
but no previous history of bronchial asthma. On admission, her
temperature was 39.4 C. Auscultation revealed wheeze in the
bilateral lung ﬁelds.
An arterial blood gas analysis on room air revealed a pH of 7.434,
PaO2 of 58.1 torr and PaCO2 of 34.2 torr, indicating hypoxemia. A
chest radiograph revealed diffuse bilateral inﬁltrates and pleural
effusion in the right lung, as shown in Fig. 1. The patient’s periph-
eral white blood cell (WBC) count was 18,600 cells/mm3, with
84.4% neutrophils, 11.8% lymphocytes and 1.0% eosinophils. The
serum C-reactive protein was 11.5 mg/dl. Her serum immuno-
globulins (Ig) were: IgG, 1048 mg/dl; IgA, 166.0 mg/dl; IgM, 199.0;
IgE, 196.8 U/ml. Bronchoalveolar lavage ﬂuid (BALF) was obtained
from right B5 area on the third hospital day. The total cell count in
the BALF was 98.0  104/ml, which contained 5.6% neutrophils,
12.0% lymphocytes and 66.6% eosinophils. The CD4/CD8 lympho-
cytes ratio in the BALF was 1.26. Cultures of the BALF
proved negative for bacteria and fungi. A specimen obtained from
Fig. 1. Chest X-rays and CT scans. A. The chest X-ray on admission showed bilateral ground-glass opaciﬁcation which was relatively right lung dominant. B. A chest CT on admission
showed diffuse ground-glass opaciﬁcation in the right lung, patchy opaciﬁcation in the left lung, and a small amount of pleural effusion in the right lung, consist with the opa-
ciﬁcation on chest X-ray. C. A chest X-ray on the seventh hospital day showed subtle opaciﬁcation, indicating remarkable improvement. D. A chest CT scan taken on the 12th hospital
day showed decreases in the patchy inﬁltrates.
Fig. 2. Serial changes in the number of eosinophils and lymphocytes in the blood. The
number of eosinophils increased gradually after the admission, and eosinophilia was
prolonged for over 1 month. The number of lymphocytes ﬂuctuated in parallel with the
number of eosinophils.
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inﬁltration with ﬁbrin exudates into the air space and edematous
alveolar walls, indicating eosinophilic pneumonia.
On the fourth hospital day, her chest radiograph and symptoms
had remarkably improved without corticosteroid treatment. Her
hypoxemia had been gradually improving, and her SpO2 was 97%
under room air on the forth hospital day. The peripheral eosinophil
count, which had been 186 cells/mm3 on admission, increased
gradually to 1400 cells/mm3 on the seventh hospital day. Although
the eosinophilia was prolonged over 1 month, the peripheral
eosinophil count decreased to 504 cells/mm3 2 months after the
development of AEP. The peripheral lymphocyte count also
increased from 2195 cells/mm3 on admission to 3367 cells/mm3 on
the seventh hospital day, and decreased to 2720 cells/mm3 2
months after the development of AEP. Therefore, the peripheral
eosinophil count appeared to ﬂuctuate in parallel with the
peripheral lymphocyte count (Fig. 2).
The patient was discharged on the 13th hospital day. She quit
smoking and has not resumed. Threemonths later, she continued to
be asymptomatic. She reported having smoked two kinds of ciga-
rettes. The lymphocyte stimulation tests (LSTs) for the both kinds of
cigarette smoke extract were negative.
A cytokine analysis of the serum was performed on admission
and on the 13th hospital day, and a cytokine analysis of the BALF
was performed on the third hospital day (Fig. 3). The levels of IL-6,
IL-5, IL-4, regulated on activation, normal T cell expressed and
secreted (RANTES) and eotaxin in the serum on admission were
28.7 pg/ml, 2590 pg/ml, 98.5 pg/ml, 20000 pg/ml and 171 pg/ml,
respectively. The cytokine analysis of the serum performed on the
13th hospital day revealed that the levels of IL-6, IL-5, IL-4 and
eotaxin had decreased to 1.0 pg/ml, <5.0 pg/ml, 71.9 pg/ml and104 pg/ml respectively, but that RANTES had increased to 78900 pg/
ml. The levels of IL-6, IL-5, IL-4, RANTES and eotaxin in the BALF
were 19.4 pg/ml, 883 pg/ml, 6.0 pg/ml, 42.1 pg/ml and 59.3 pg/ml,
respectively. The levels of all cytokines in the BALF were lower than
those in the serum obtained on admission. In particular, the level of
RANTES in the BALF was much lower than that in the serum.
Fig. 3. The result of the cytokine analysis of the BALF and serum. The cytokine analysis of the BALF was performed on the third hospital day. The cytokine analysis of the serumwas
performed on admission and the 13th hospital day.
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Allen et al. proposed a set of diagnostic criteria for AEP, which is
(1) acute febrile illness < 5 day in duration; (2) hypoxemic respi-
ratory failure; (3) diffuse alveolar or mixed alveolar-interstitial
chest X-ray inﬁltrates; (4) BAL eosinophils greater than 25%; (5)
an absence of parasitic, fungal, or other infection; (6) prompt and
complete response to corticosteroids; and (7) failure to relapse after
discontinuation of corticosteroids.10 This case met most of these
diagnostic criteria andwas therefore diagnosed as AEP. The cause of
the AEP in this case is thought to be cigarette smoking, because the
patient had started smoking just before the development of AEP,
and showed spontaneous improvement after cigarette smoking
cessationwithout corticosteroid treatment. A fewother cases of AEP
following cigarette smoking like this case have been reported pre-
viously.2e6 Among these reports, there have been some reports that
have proven that cigarette smoking induces AEP by the cigarette
smoking challenge test.24 Although the optimal method to prove
the association between cigarette smoking and AEP is the cigarette
smoking challenge test, she refused to perform the cigarette
smoking challenge test. The best reported candidate as an alterna-
tive method is LST.11 In the present, the LST for cigarette smoke
extract was negative. However, this may be been because the LST
positive rate is not necessarily high, and may not have been
detectable.12,13 Another possible cause is the timing of when the LST
was performed, because AEP has been reported to show tolerance
for cigarette smoking over time.3 In the present study, we per-
formed the LST after the AEP had improved. To understand the
signiﬁcance of the LST, and its potential use as an alternative to the
cigarette smoking challenge, further investigations will be needed.
The most characteristic feature of AEP is pulmonary eosino-
philia. Although the precise mechanism of accumulation in the
lungs remains to be elucidated, previous studies indicated that
some cytokines are involved in the eosinophil accumulation in thelungs.14 The cytokines which were reported to be involved in
eosinophil accumulation in the lung are IL-3, IL-4, IL-5, IL-8,
eotaxin, RANTES and GM-CSF, among others.14 IL-3, IL-5 and GM-
CSF have been recognized as activators of eosinophil function,
including migration into the alveoli. IL-5 is reported to be a major
factor for in eosinophil accumulation in AEP.9 Chemokines such as
eotaxin, IL-8 and RANTES, have also been found to be eosinophil
chemoattractants. The levels of these chemokines in BALF are
reported to increase in eosinophilic pneumonia.15 Furthermore, the
cooperation between eotaxin and IL-5 to induce eosinophil accu-
mulation has been reported by several investigators.16,17 The
expression of eotaxin and IL-5 is up-regulated by IL-4.18,19 We
evaluated the changes in the levels of cytokines using serum and
BALF in this case. The levels of IL-4, IL-5, IL-6 and eotaxin in serum
were high on admission and decreased on the clinical course, thus
indicating that these cytokines likely played an important role in
the early phase of the condition.
In contrast, the levels of RANTES in the serum increased, thus
suggesting that RANTES might play an important role in the
convalescent phase. In addition, the level of RANTES in the BALF
was much lower than that in the serum, especially compared with
the other cytokines. These ﬁndings might indicate that RANTES did
not play an important role in the eosinophil accumulation in the
lung. Interestingly blood eosinophilia was observed after the
improvement of the lung involvement in this case. In a previous
report, although blood eosinophilia after improvement was
reported, the responsible cytokines were not known, because there
were no cytokines that increased in parallel with the eosinophils in
blood.8 These ﬁndings which were observed in this case suggest
that RANTES might be involved in the blood eosinophilia after
improvement. RANTES is known to attract not only eosinophils, but
also T cells, including memory subtype T cells, Th1, CD8þ T cells and
FoxP3þ T cells.2023 Given that the lymphocyte counts in the blood
increased in parallel with the eosinophil count with time course in
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phils, but also in lymphocytes in the blood after the improvement
of AEP. In a previous report, CD8þCD11b T cells were reported to
increase in the BALF after the improvement of AEP and were
speculated to be involved in the improvement through their
suppressive effect on cell activity.24 Although the subtype and role
of the lymphocytes that increased in this case are not known, there
is a possibility that lymphocytes which have the ability to suppress
the immune responsewere attracted by RANTES andwere involved
in the spontaneous improvement in this case.
To our knowledge, this is a ﬁrst report which evaluated the
expression of cytokines in a case of AEP showing spontaneous
improvement. The analysis of the cytokines revealed that RANTES,
which is a potent chemoattractant for eosinophils and lympho-
cytes, increased after the improvement. The precise role of RANTES
in AEP is unknown. However, the ﬁndings which were observed in
this case, including the increased number of eosinophils, lympho-
cytes and the level of RANTES in the convalescent phase, prompted
us to suggest that RANTES might induce an increase in eosinophils
and lymphocytes in the convalescent phase, and may be associated
with the spontaneous improvement in AEP. Further investigations
of the role of RANTES may contribute to the understanding of the
pathogenesis of AEP.
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